Navigation Links
Meningitis C Surfaces in Toronto:Public Alerted

A young man died of Meningitis C last week. Public health department in Toronto has alerted its citizens regarding this case //since the disease is highly contagious and the man who died happened to have frequented a bustling bar days before he died.

Although only a single case has been notified, owing to its severity and fatality, the health department has alerted the public to be cautious. Meningitis C is a contagious disease caused by bacteria present in the throat and saliva of an infected person. It can typically spread through mouth –to-mouth kissing and sharing drinks. It can be fatal in one tenth of cases. Following exposure, symptoms show up within 2 – 5 days. Severe headache, high fever, nausea and stiff neck are the chief symptoms. Typically it affects the younger generation.

The young man who died last week in Toronto had visited Crews & Tango, a bar, frequented by hundreds of patrons during weekends. All patrons who had visited that bar, have been alerted and urged to take precautionary vaccines. Health officials have notified that free vaccinations are being made available to the public at the 519 Church Street Community Centre from 3-7pm on Friday.

There were no Meningitis C cases reported in Toronto last year.
MST
'"/>




Page: 1

Related medicine news :

1. Meningitis C vaccine a cost-effective success
2. Cure for Bacterial Meningitis
3. Efficacy Of Meningitis C Vaccine
4. Meningitis is rocking the capital again
5. Uganda Tackles The Meningitis Outbreak
6. Fatal Case of Meningitis Detected In Massachusetts
7. Meningitis Back in Delhi and 21 Dead
8. New Delhi Hit By Meningitis Deaths
9. Cost-effective Meningitis Vaccine To Be Launched In Africa
10. Delhi Witnessed 34 Meningitis Deaths In Three Months
11. Meningitis vaccine in a controversy regarding efficacy
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/27/2016)... ... 2016 , ... Two director-level employees of Horizon Blue Cross Blue Shield of ... 2016 honorees. The award recognizes businesswomen who excel in their fields and who ... the MLTSS (Managed Long-Term Services and Supports) Program at Horizon NJ Health and Theresa ...
(Date:5/27/2016)... ... May 27, 2016 , ... W.S. Badger Co. Inc ., the maker ... been recognized as one of the best small businesses for new dads by Fatherly, ... nine small businesses providing progressive benefits to new parents on the organization’s 2016 ...
(Date:5/27/2016)... ... May 27, 2016 , ... An influential resource amongst nurses ... time to shed lights on the variety of topics detailing why we appreciate nurses ... tackles why this career has gone from being in a major recession to one ...
(Date:5/27/2016)... York, NY (PRWEB) , ... May 27, 2016 , ... ... needing intervention to walk, the demand for a sustainable product to aid in the ... void and aid in the recovery of individuals with hemiplegia due to stroke. , ...
(Date:5/27/2016)... ... ... This campaign aims to provide a path to improved education and awareness ... change. , As nearly 795,000 Americans suffering from a new or recurrent stoke each ... an estimated 129,000 of these people dying from stroke, it’s become our nation’s fifth-leading ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... -- According to the 2016 report, a ... blood pressure monitoring system market growth. With aging, the ... respond to different pressure rates, leading to hypertension or ... cardiovascular disorders such as heart failure, stroke, coronary artery ... in prevalence each year. WHO estimates that 17 million ...
(Date:5/27/2016)... , May 27, 2016 ... innovative biopharma company focused on the highly lucrative ... a substantial pipeline of potential first-in-class or best-in-class ... are in development with strategic partners. HCM,s profitable ... fast-growing domestic market. We expect progress of the ...
(Date:5/27/2016)... TEL-AVIV, Israel , May 27, 2016 /PRNewswire/ ... KTOV), an innovative biopharmaceutical company focused on late-stage ... by Dexcel Pharma of pivotal batches ... Food and Drug Administration (FDA). This follows Kitov,s ... pivotal Phase III trial successfully met its primary ...
Breaking Medicine Technology: